Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016078 · ClinicalTrials.gov registry record · NA
Self-adherent Absorbent Silver Dressing in Adults After Hip or Knee Arthroplasty
A NA study, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03016078 is a NA study that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 21 participants.
The verdict
NCT03016078, a NA study, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The overall rationale for this investigation is to evaluate the clinical performance potential for Mepilex Border Post-Op Ag in the ability to minimize the risk of skin related post-operative wound complications such as blistering, maceration and redness at the incision and surrounding skin.
Interventions
- DEVICE Mepilex Border Post-Op Ag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2017-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03016078
The ClinicalTrials.gov registry entry for NCT03016078 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mepilex Border Post-Op Ag is the first listed.
NCT03016078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03016078 about?
NCT03016078 is a clinical study titled "Self-adherent Absorbent Silver Dressing in Adults After Hip or Knee Arthroplasty". The overall rationale for this investigation is to evaluate the clinical performance potential for Mepilex Border Post-Op Ag in the ability to minimize the risk of skin related post-operative wound complications such as blistering, maceration and redness at the incision and surrounding skin.
What is the current status of trial NCT03016078?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-02-01. Estimated completion is 2017-04-07.
What interventions are being tested in trial NCT03016078?
The interventions under investigation include: Mepilex Border Post-Op Ag (DEVICE).
Who is sponsoring clinical trial NCT03016078?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.